Wacker Biotech News and Resources

MinervaX ApS, a Danish biotechnology firm, has entered a collaboration with Wacker Biotech, a contract development and manufacturing organisation (CDMO), to manufacture the active protein ingredients for its Group B Streptococcus (GBS) vaccine. MinervaX is developing a novel prophylactic vaccine